Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Whole genome sequencing of leukemias from MCM2 transgenic mice

PROVIDER: PRJNA565491 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10119943_1.fastq.gz	Fastqsanger.gz
	SRR10119943_2.fastq.gz	Fastqsanger.gz
	SRR10119944_1.fastq.gz	Fastqsanger.gz
	SRR10119944_2.fastq.gz	Fastqsanger.gz
	SRR10119945_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Project description:Whole exome sequencing of leukemias from MCM2 transgenic mice

| PRJNA799024 | ENA

Project description:Whole exome sequencing of leukemias from MCM2 transgenic mice

| PRJNA565494 | ENA

Project description:Custom targeted sequencing on Leukemias from MCM2 transgenic mice

| PRJNA565492 | ENA

Leukemias from NP23-NHD13 double transgenic mice - WES study

Project description:Whole exome sequencing (the SureSelectXT Mouse All Exon Kit) was done on leukemias from NP23-NHD13 double transgenic mice with strain background designated “C57Bl6-NIH”.

2020-09-10 | GSE137542 | GEO

Project description:Whole exome sequencing of leukemias from NP23-NHD13 double transgenic mice

| PRJNA565250 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Effect of mini-chromosome maintenance protein 2 deficiency on the locations of DNA replication origins

Project description:Mini-chromosome maintenance (MCM) proteins are loaded to chromatin during G1-phase and define potential locations of DNA replication initiation. MCM protein deficiency results in genome instability and high rates of cancer in mouse models. Here we develop a method of nascent strand capture and release and show that MCM2 deficiency reduces DNA replication initiation in gene rich regions of the genome. DNA structural properties are shown to correlate with sequence motifs associated with replication origins and with locations that are preferentially affected by MCM2 deficiency. Reduced nascent strand density correlates with sites of recurrent focal CNVs in tumors arising in MCM2-deficient mice, consistent with a direct relationship between sites of reduced DNA replication initiation and genetic damage. Between 10 and 90% of human tumors, depending on type, carry heterozygous loss or mutation of one or more Mcm2-7 genes which is expected to compromise DNA replication origin licensing and result in elevated rates of genome damage at a subset of gene rich locations. Mcm2 deficient vs. wild type

2015-01-14 | E-GEOD-64933 | biostudies-arrayexpress

TF ChIP-seq of human acute leukemias

Project description:CEBPA/PU.1/TCF7 ChIP-seq of 6 primary samples derived from human acute leukemias, namely AML, T-ALL and mixed myeloid/lymphoid leukemias with CpG Island Methylator Phenotype (CIMP). Low-coverage whole genome sequencing (ChIP input) of the same samples is also included as a control to be used in peak calling.

2024-05-27 | E-MTAB-14060 | biostudies-arrayexpress

Leukemias from NP23-NHD13 double transgenic mice - WES study

Project description:Leukemias from NP23-NHD13 double transgenic mice - WES study

| PRJNA565806 | ENA

Effect of mini-chromosome maintenance protein 2 deficiency on the locations of DNA replication origins

2015-01-14 | GSE64933 | GEO